Treatment of persistent or recurrent type 2 diabetes after metabolic surgery

Geltrude Mingrone

doi:10.1016/S2213-8587(19)30195-0

Treatment of persistent or recurrent type 2 diabetes after metabolic surgery

Geltrude Mingrone^*

^*Corresponding author

Research output: Contribution to journal › Article

1 Citation (Scopus)

Abstract

N/A

Original language	English
Pages (from-to)	504-505
Number of pages	2
Journal	THE LANCET DIABETES & ENDOCRINOLOGY
Volume	7
DOIs	https://doi.org/10.1016/S2213-8587(19)30195-0
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

type 2 diabetes, metabolic surgery

Access to Document

10.1016/S2213-8587(19)30195-0

Cite this

@article{897268564ff34a8ebdf9db502ad10af8,

title = "Treatment of persistent or recurrent type 2 diabetes after metabolic surgery",

abstract = "N/A",

keywords = "type 2 diabetes, metabolic surgery, type 2 diabetes, metabolic surgery",

author = "Geltrude Mingrone",

year = "2019",

doi = "10.1016/S2213-8587(19)30195-0",

language = "English",

volume = "7",

pages = "504--505",

journal = "THE LANCET DIABETES \& ENDOCRINOLOGY",

issn = "2213-8587",

publisher = "Amsterdam : Elsevier",

}

TY - JOUR

T1 - Treatment of persistent or recurrent type 2 diabetes after metabolic surgery

AU - Mingrone, Geltrude

PY - 2019

Y1 - 2019

N2 - N/A

AB - N/A

KW - type 2 diabetes, metabolic surgery

UR - http://hdl.handle.net/10807/148110

UR - http://www.journals.elsevier.com/the-lancet-diabetes-and-endocrinology

U2 - 10.1016/S2213-8587(19)30195-0

DO - 10.1016/S2213-8587(19)30195-0

M3 - Article

SN - 2213-8587

VL - 7

SP - 504

EP - 505

JO - THE LANCET DIABETES & ENDOCRINOLOGY

JF - THE LANCET DIABETES & ENDOCRINOLOGY

ER -

Treatment of persistent or recurrent type 2 diabetes after metabolic surgery

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this